key: cord-0698334-k2yi6kas
authors: Shah, Priyank; Olarewaju, Ayodeji
title: The authors reply
date: 2021-05-25
journal: Crit Care Med
DOI: 10.1097/ccm.0000000000005135
sha: ce98ce50c6a42d95a6d66a1690f7c6800f3ea38d
doc_id: 698334
cord_uid: k2yi6kas

nan

t the time of submission of our recently published article (1) in Critical Care Medicine, there were no data regarding survival after in-hospital cardiac arrest among coronavirus disease 2019 (COVID-19) patients in the United States. We acknowledge that our study (1) raised concerns regarding the benefit of cardiopulmonary resuscitation (CPR) in hospitalized COVID-19 patients suffering cardiac arrest. However, the goal of our study (1) was to initiate robust debate and encourages further research into a very important question that has a significant impact on resource allocation. We did not suggest early termination of resuscitative efforts or premature withdrawal of life-sustaining measures for such patients.

We agree with the authors that based on recent larger studies, CPR is not universally futile in hospitalized COVID-19 patients. However, our study (1) was unique in terms of patient demographics. More than 90% of patients in our study (1) were African-Americans. It is well known that African-Americans have significantly lower survival rates after cardiac arrest compared with Caucasian patients (2) . Furthermore, our hospitalized COVID-19 patients were sicker with higher comorbidity burden compared with other areas (3).

We would like to point out that we have mentioned the lack of generalizability of our findings in the Limitations section of our article (1) due to our unique patient population as well as the fact that it was a single-center study. We completely agree with the authors (4) that providers, patients, and families should exercise caution in using findings from single-center studies such as ours (1) to make decisions regarding resuscitative measures. We believe that goals of care conversations should be a core component of the care pathway for every critically ill patient at every stage of their care in the hospital. We hope our study (1) will encourage future research to explore racial differences in the outcomes of cardiac arrest in COVID-19 patients.

To the Editor: Since early in the pandemic, concerns have been raised about low survival rates after IHCA in patients with COVID-19. First, a study from Wuhan demonstrated very low survival in a cohort of 136 patients with COVID-19 who suffered IHCA (2) . However, in this cohort, greater than 90% of patients presented with asystole-raising the question of delayed recognition of IHCA in a hospital overrun with the first surge of COVID-19. The study by Shah et al (1) and several other small single-center cohorts with similarly low survival led to discussions of blanket do-not-resuscitate orders in both the medical literature and the lay press. However, recent multicenter publications, including one by our own study group, suggest that IHCA from COVID-19 is far from futile. Our retrospective cohort study of IHCA across 11 hospitals demonstrated an overall return of spontaneous circulation (ROSC) rate of 22.3% and 11.9% survival to hospital discharge, with marked variation between centers (3) . Hayek et al (4) , in another multicenter study, reported rates of ROSC of 33.8% and 12% survival to hospital discharge in patients admitted to the ICU.

IHCA strikes approximately 300,000 patients every year in the United States; approximately 25% survive to hospital discharge (5). However, survival varies widely between centers due to differences in patient characteristics, resuscitation practices, and postarrest care implementation (5). The COVID-19 pandemic combined with local practice decisions has the potential to dramatically affect the continuum of IHCA care, including the prompt

Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease

Is cardiopulmonary resuscitation futile in coronavirus disease 2019 patients experiencing in-hospital cardiac arrest?

American Heart Association National Registry of Cardiopulmonary Resuscitation (NRCPR) Investigators: Racial differences in survival after in-hospital cardiac arrest

Demographics, comorbidities, and outcomes in hospitalized Covid-19 patients in rural Southwest Georgia

Questioning the Futility of Cardiopulmonary Resuscitation in Patients With Severe Coronavirus Disease 2019